Drug-associated vasculitis occurring after treatment with pembrolizumab

Rheumatology (Oxford). 2019 Aug 1;58(8):1501-1503. doi: 10.1093/rheumatology/kez051.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antineoplastic Agents, Immunological / adverse effects*
  • Female
  • Humans
  • Melanoma / drug therapy*
  • Middle Aged
  • Vasculitis / chemically induced*

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Immunological
  • pembrolizumab